ARCHIVES

IOM Committee Will Probe Duke Scandal Together With Other “Omics” Case Studies

This article is from The Cancer Letter archive.

Vol. 37 No. 01 | January 7, 2011

Download PDF Visit The Full Archive

Related Articles

In Vote Against Tarceva As Maintenance, ODAC Seeks Stronger Survival Benefit

December 18, 2009

ASCO Recommends Against Chemo In Stage II Colon Cancer

June 25, 2004

Women’s Caucus Calls For Wide Mammogram Payment

March 18, 1994

In Brief: FDA To Review Preclinical Testing, Phase I Protocols At Open Advisory Group Meeting

November 14, 1975

What? Only a “B”? NLST Co-Principal Investigator Begs to Differ with USPSTF Lung Cancer Screening Grade

August 9, 2013

ACS Prostate Cancer Recommendations Move Forward

August 7, 1992